| 1 |
Rd BA, Venook AP, Bekaii－Saab T, et al. Rectal cancer, version 2.2015[J]. Journal of the National Comprehensive Cancer Network Jnccn, 2015, 13(6): 719-728.
|
| 2 |
Glimelius B, Tiret E, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow－up[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology, 2013, 24 (5): 81-88.
|
| 3 |
Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12－Year follow－up of the multicentre, randomised controlled TME trial[J]. Lancet Oncol，2011，12(6): 575-582.
|
| 4 |
Cedermark B, Dahlberg M, Glimelius B, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer[J]. N Engl J Med，1997，336(14): 980-987.
|
| 5 |
Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR Ⅱ): short－term outcomes of a randomised, phase 3 trial[J]. Lancet Oncol，2013，14(3): 210-218.
|
| 6 |
Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer[J]. N Engl J Med，2015，372(14): 1324-1332.
|
| 7 |
Hu JJ, Liang JW, Wang Z, et al. Short－term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single－center experience[J]. J Surg Res，2014，187(2): 438-444.
|
| 8 |
Chen H, Zhao L, An S, et al. Laparoscopic versus open surgery following neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta－analysis[J]．J Gastrointest Surg，2014，18(3): 617-626.
|
| 9 |
佚名．中国结直肠癌诊疗规范(2015版)[J/CD]. 中华普通外科学文献(电子版)，2015，9(6): 506-523.
|
| 10 |
Peng J, Lin J, Qiu M, et al. Clinical factors of post－chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer[J]. Clinics (Sao Paulo)，2016，71(8): 449-454.
|
| 11 |
Lefevre JH, Mineur L, Kotti S, et al. Effect of Interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR－6)[J]. J Clin Oncol，2016，34(31): 3773-3780.
|
| 12 |
Lin JZ, Peng JH, Qdaisat A, et al. Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low－lying locally advanced rectal cancer based on an oncologic outcome study[J]. Oncotarget，2016，7(35): 57317-57326.
|
| 13 |
Cong ZJ, Hu LH, Bian ZQ, et al. Systematic review of anastomotic leakage rate according to an international grading system following anterior resection for rectal cancer[J]. PLOS One，2013，8(9): 75519.
|
| 14 |
Kulu Y, Tarantio I, Warschkow R, et al. Anastomotic leakage is associated with impaired overall and disease－free survival after curative rectal cancer resection: a propensity score analysis[J]. Ann Surg Oncol，2015，22(6): 2059-2067.
|
| 15 |
Marinatou A, Theodoropoulos GE, Karanika S, et al. Do anastomotic leaks impair postoperative health－related quality of life after rectal cancer surgery? a case－matched study[J]. Dis Colon Rectum，2014，57(2): 158-166.
|
| 16 |
McDermott FD, Heeney A, Kelly ME, et al. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks[J]. Br J Surg，2015，102(5): 462-479.
|
| 17 |
Leif S, Nicole W, Michael G, et al. Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications[J]. BMC Surgery, 2013, 13(1): 43-43.
|
| 18 |
Yoshioka Y, Uehara K, Ebata T, et al. Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer[J]. Surg Today，2014，44(7): 1300-1306.
|
| 19 |
Huser N, Michalski CW, Erkan M, et al. Systematic review and meta－analysis of the role of defunctioning stoma in low rectal cancer surgery[J]. Ann Surg，2008，248(1): 52-60.
|
| 20 |
Gu W, Wu S. Meta－analysis of defunctioning stoma in low anterior resection with total mesorectal excision for rectal cancer: evidence based on thirteen studies[J]. World Journal of Surgical Oncology, 2015, 13(1): 9-9.
|
| 21 |
Zhou X, Wang B, Li F, et al. Risk factors associated with nonclosure of defunctioning stomas after sphincter－preserving low anterior resection of rectal cancer: a meta－analysis[J]. Dis Colon Rectum，2017，60(5): 544-554.
|
| 22 |
Cartmell MT, Jones OM, Moran BJ, et al. A defunctioning stoma significantly prolongs the length of stay in laparoscopic colorectal resection[J]. Surg Endosc，2008，22(12): 2643-2647.
|
| 23 |
Koperna T. Cost－effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking[J]. Arch Surg. 2003，138(12): 1334-1339.
|
| 24 |
Ameda K, Kakizaki H, Koyanagi T, et al. The long－term voiding function and sexual function after pelvic nerve－sparing radical surgery for rectal cancer[J]. Int J Urol. 2005，12(3): 256-263.
|
| 25 |
Liu Z, Huang M, Kang L, et al. Prognosis and postoperative genital function of function－preservative surgery of pelvic autonomic nerve preservation for male rectal cancer patients[J]. Bmc Surgery, 2016, 16(1): 1-7.
|